Furthermore, we performed a multivariate analysis with four variables (LOXL1 expression, depth of tumor invasion, lymph node metastasis, distant metastases) among all eight variables affecting overall survival in univariate analyses in the Kyushu validation cohort. The gene discussed is LOXL1; the disease is metastatic malignant neoplasm in the lymph nodes.